Callosal atrophy in mild cognitive impairment and Alzheimer's disease: Different effects in different stages

NeuroImage

Volumn 49, Issue 1, 2010, Pages 141-149

  Di Paola, Margherita ^a,b   Luders, Eileen ^c   Di Iulio, Fulvia ^a   Cherubini, Andrea ^a   Passafiume, Domenico ^b   Thompson, Paul M ^c   Caltagirone, Carlo ^a,d   Toga, Arthur W ^c   Spalletta, Gianfranco ^a  

^a IRCCS FONDAZIONE SANTA LUCIA   (Italy)

^b UNIVERSITY OF L'AQUILA   (Italy)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

Amnesic MCI; Corpus callosum; Mild AD; Region of interest; Severe AD; Voxel based morphometry

Indexed keywords

ALZHEIMER DISEASE; ARTICLE; BRAIN ATROPHY; CLINICAL ARTICLE; CONTROLLED STUDY; CORPUS CALLOSUM; DISEASE COURSE; DISEASE SEVERITY; GRAY MATTER; HUMAN; IMAGE ANALYSIS; IMAGE DISPLAY; MILD COGNITIVE IMPAIRMENT; NEUROPATHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; WHITE MATTER;

AGED; ALZHEIMER DISEASE; AMNESIA; ATROPHY; COGNITION DISORDERS; CORPUS CALLOSUM; DISEASE PROGRESSION; FUNCTIONAL LATERALITY; HUMANS; MAGNETIC RESONANCE IMAGING; NEUROPSYCHOLOGICAL TESTS;

EID: 70349970009     PISSN: 10538119     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroimage.2009.07.050     Document Type: Article

References (84)

1. Aboitiz F., and Montiel J. One hundred million years of interhemispheric communication: the history of the corpus callosum. Braz. J. Med. Biol. Res. 36 (2003) 409-420
2. Aboitiz F., Scheibel A.B., Fisher R.S., and Zaidel E. Fiber composition of the human corpus callosum. Brain Res. 598 (1992) 143-153
3. Aboitiz F., Rodríguez E., Olivares R., and Zaidel E. Age-related changes in fibre composition of the human corpus callosum, sex differences. Neuroreport 7 (1996) 1761-1764
4. Ashburner J., and Friston K.J. Voxel-based morphometry - the methods. NeuroImage 11 (2000) 805-821
5. Ashburner J., and Friston K.J. Unified segmentation. NeuroImage 26 (2005) 839-851
6. Atlas S.W., Zimmerman R.A., Bilaniuk L.T., Rorke L., Hackney D.B., Goldberg H.I., and Grossman R.I. Corpus callosum and limbic system: neuroanatomic MR evaluation of developmental anomalies. Radiology 160 (1986) 355-362
7. Barkovich A.J. Apparent atypical callosal dysgenesis: analysis of MR findings in six cases and their relationship to holoprosencephaly. AJNR Am. J. Neuroradiol. 11 (1990) 333-339
8. Barkovich A.J. Magnetic resonance imaging: role in the understanding of cerebral malformations. Brain Dev. 24 (2002) 2-12
9. Barkovich A.J., Simon E.M., and Walsh C.A. Callosal agenesis with cyst: a better understanding and new classification. Neurology 56 (2001) 220-227
10. Bartzokis G. Age-related myelin breakdown, a developmental model of cognitive decline and Alzheimer's disease. Neurobiol. Aging 25 (2004) 5-18
11. Black S.E., Moffat S.D., Yu D.C., Parker J., Stanchev P., and Bronskill M. Callosal atrophy correlates with temporal lobe volume and mental status in Alzheimer's disease. Can. J. Neurol. Sci. 27 (2000) 204-209
12. Braak H., and Braak E. Neuropathological stageing of Alzheimer-related changes. Acta. Neuropathol. 82 (1991) 239-259
13. Braak H., and Braak E. Frequency of stages of Alzheimer-related lesions in different age categories. Neurobiol. Aging 18 (1997) 351-357
14. Braak H., Del Tredici K., Schultz C., and Braak E. Vulnerability of select neuronal types to Alzheimer's disease. Ann. N.Y. Acad. Sci. 924 (2000) 53-61
15. Bronge L., Bogdanovic N., and Wahlund L.O. Postmortem MRI and histopathology of white matter changes in Alzheimer brains. A quantitative, comparative study. Dement. Geriatr. Cogn. Disord. 13 (2002) 205-212
16. Brun A., and Englund E. A white matter disorder in dementia of the Alzheimer type, a pathoanatomical study. Ann. Neurol. 19 (1986) 253-262
17. Bookstein F.L. "Voxel-based morphometry" should not be used with imperfectly registered images. NeuroImage 14 (2001) 1454-1462
18. Carlesimo G.A., Caltagirone C., and Gainotti G. The mental deterioration battery, normative data, diagnostic reliability and qualitative analyses of cognitive impairment. The Group for the Standardization of the Mental Deterioration Battery. Eur. Neurol. 36 (1996) 378-384
19. Chaim T.M., Duran F.L., Uccida R.R., Pirico C.A., de Castro C.C., and Buratto G.F. Volumetric reduction of the corpus callosum in Alzheimer's disease in vivo as assessed with voxel-based morphometry. Psychiatry Res. 154 (2007) 59-68
20. Chua T.C., Wen W., Slavin M.J., and Sachdev P.S. Diffusion tensor imaging in mild cognitive impairment and Alzheimer's disease: a review. Curr. Opin. Neurol. 21 (2008) 83-92
21. Deichmann R., Schwarzbauer C., and Turner R. Optimisation of the 3D MDEFT sequence for anatomical brain imaging: technical implications at 1.5 and 3 T. Neuroimage 21 (2004) 757-767
22. Fellgiebel A., Wille P., Müller M.J., Winterer G., Scheurich A., Vucurevic G., Schmidt L.G., and Stoeter P. Ultrastructural hippocampal and white matter alterations in mild cognitive impairment, a diffusion tensor imaging study. Dement. Geriatr. Cogn. Disord. 18 (2004) 101-108
23. Folstein M.F., Folstein S.E., and McHigh P.R. The "mini-mental state", a practical method for grading the cognitive state of patients for the clinicians. J. Psychiatr. Res. 12 (1975) 189-198
24. Frisoni G.B., Pievani M., Testa C., Sabattoli F., Bresciani L., Bonetti M., Beltramello A., Hayashi K.M., Toga A.W., and Thompson P.M. The topography of grey matter involvement in early and late onset Alzheimer's disease. Brain 130 (2007) 720-730
25. Galton C.J., Patterson K., Xuereb J.H., and Hodges J.R. Atypical and typical presentations of Alzheimer's disease, a clinical, neuropsychological, neuroimaging and pathological study of 13 cases. Brain 123 (2000) 484-498
26. Good C.D., Johnsrude I.S., Ashburner J., Henson R.N.A., Friston K.J., and Frackowiak R.S. A voxel-based morphometry study of ageing in 465 normal adult human brains. NeuroImage 14 (2001) 21-36
27. Good C.D., Scahill R.I., Fox N.C., Ashburner J., Friston K.J., Chan D., Crum W.R., Rossor M.N., and Frackowiak R.S. Automatic differentiation of anatomical patterns in the human brain, validation with studies of degenerative dementias. NeuroImage 17 (2002) 29-46
28. Hallam B.J., Brown W.S., Ross C., Buckwalter J.G., Bigler E.D., Tschanz J.T., Norton M.C., Welsh-Bohmer K.A., and Breitner J.C. Regional atrophy of the corpus callosum in dementia. J. Int. Neuropsychol. Soc. 14 (2008) 414-423
29. Hampel H., Teipel S.J., Alexander G.E., Horwitz B., Teichberg D., Schapiro M.B., and Rapoport S.I. Corpus callosum atrophy is a possible indicator of region- and cell type-specific neuronal degeneration in Alzheimer disease, a magnetic resonance imaging analysis. Arch. Neurol. 55 (1998) 193-198
30. Hampel H., Teipel S.J., Alexander G.E., Pogarell O., Rapoport S.I., and Moller H.J. In vivo imaging of region and cell type specific neocortical neurodegeneration in Alzheimer's disease. Perspectives of MRI derived corpus callosum measurement for mapping disease progression and effects of therapy. Evidence from studies with MRI, EEG and PET. J. Neural. Transm. 109 (2002) 837-855
31. Hanyu H., Asano T., Sakurai H., Imon Y., Iwamoto T., Takasaki M., Shindo H., and Abe K. Diffusion-weighted and magnetization transfer imaging of the corpus callosum in Alzheimer's disease. J. Neurol. Sci. 167 (1999) 37-44
32. Hensel A., Wolf H., Kruggel F., Riedel-Heller S.G., Nikolaus C., Arendt T., and Gertz H.J. Morphometry of the corpus callosum in patients with questionable and mild dementia. J. Neurol. Neurosurg. Psychiatry 73 (2002) 59-61
33. Hensel A., Ibach B., Muller U., Kruggel F., Kiefer M., and Gertz H.J. Does the pattern of atrophy of the Corpus callosum differ between patients with frontotemporal dementia and patients with Alzheimer's disease?. Dement. Geriatr. Cogn. Disord. 18 (2004) 44-49
34. Hensel A., Wolf H., Busse A., Arendt T., and Gertz H.J. Association between global brain volume and the rate of cognitive change in elderly humans without dementia. Dement. Geriatr. Cogn. Disord. 19 (2005) 213-221
35. Hofer S., and Frahm J. Topography of the human corpus callosum revisited-comprehensive fiber tractography using diffusion tensor magnetic resonance imaging. NeuroImage 32 (2006) 989-994
36. Hua X., Leow A.D., Lee S., Klunder A.D., Toga A.W., Lepore N., Chou Y.Y., Brun C., Chiang M.C., Barysheva M., Jack Jr. C.R., Bernstein M.A., Britson P.J., Ward C.P., Whitwell J.L., Borowski B., Fleisher A.S., Fox N.C., Boyes R.G., Barnes J., Harvey D., Kornak J., Schuff N., Boreta L., Alexander G.E., Weiner M.W., Thompson P.M., and Alzheimer's Disease Neuroimaging Initiative. 3D Characterization of brain atrophy in Alzheimer's disease and mild cognitive impairment using tensor-based morphometry. NeuroImage 41 (2008) 19-34
37. Hua, X., Leow, A.D., Parikshak, N., Lee, S., Chiang, M.C., Toga, A.W., Jack, C.R., Weiner, M.W., Thompson, P.M., 2008b. Tensor-Based Morphometry as a Neuroimaging Biomarker for Alzheimer's Disease, An MRI Study of 676 AD, MCI, and Normal Subjects. NeuroImage 43, 458-469.
38. Hughes C.P., Berg L., Danziger W.L., Coben L.A., and Martin R.L. A new clinical scale for the staging of dementia. Br. J. Psychiatry 140 (1982) 566-572
39. Kaufer D.I., Miller B.L., Itti L., Fairbanks L.A., Li J., Fishman J., Kushi J., and Cummings J.L. Midline cerebral morphometry distinguishes frontotemporal dementia and Alzheimer's disease. Neurology 48 (1997) 978-985
40. Keller S.S., Wilke M., Wieshmann U.C., Sluming V.A., and Roberts N. Comparison of standard and optimized voxel-based morphometry for analysis of brain changes associated with temporal lobe epilepsy. NeuroImage 23 (2004) 860-868
41. Li S., Pu F., Shi F., Xie S., Wang Y., and Jiang T. Regional white matter decreases in Alzheimer's disease using optimized voxel-based morphometry. Acta. Radiol. 49 (2008) 84-90
42. Luders E., Narr K.L., Zaidel E., Thompson P.M., Jancke L., and Toga A.W. Parasagittal asymmetries of the corpus callosum. Cereb. Cortex 16 (2006) 346-354
43. Luders E., Di Paola M., Tomaiuolo F., Thompson P.M., Toga A.W., Vicari S., Petrides M., and Caltagirone C. Callosal morphology in Williams syndrome, a new evaluation of shape and thickness. Neuroreport 18 (2007) 203-207
44. Lyoo I.K., Satlin A., Lee C.K., and Renshaw P.F. Regional atrophy of the corpus callosum in subjects with Alzheimer's disease and multi-infarct dementia. Psychiatry Res. 74 (1997) 63-72
45. Mazziotta J., Toga A., Evans A., Fox P., Lancaster J., Zilles K., Woods R., Paus T., Simpson G., Pike B., Holmes C., Collins L., Thompson P., MacDonald D., Iacoboni M., Schormann T., Amunts K., Palomero-Gallagher N., Geyer S., Parsons L., Narr K., Kabani N., Le Goualher G., Boomsma D., Cannon T., Kawashima R., and Mazoyer B. A probabilistic atlas and reference system for the human brain. Philos. Trans. R. Soc. Lond. B. Biol. Sci. 356 (2001) 1293-1322
46. McKhann G., Drachman D., Folstein M., Katzman R., Price D., and Stadian E.M. Clinical diagnosis of Alzheimer's disease, report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 34 (1984) 939-944
47. Neil J., Miller J., Mukherjee P., and Hüppi P.S. Diffusion tensor imaging of normal and injured developing human brain - a technical review. NMR Biomed. 15 (2002) 543-552
48. Ortiz Alonso T., Martínez Castillo E., Fernández Lucas A., Arrazola García J., Maestú Unturbe F., and López-Ibor J.J. Callosal atrophy and associated electromyographic responses in Alzheimer's disease and aging. Electromyogr. Clin. Neurophysiol. 40 (2000) 465-475
49. Pantel J., Schröder J., Jauss M., Essig M., Minakaran R., Schönknecht P., Schneider G., Schad L.R., and Knopp M.V. Topography of callosal atrophy reflects distribution of regional cerebral volume reduction in Alzheimer's disease. Psychiatry Res. 90 (1999) 181-192
50. Petersen R.C., Smith G.E., Waring S.C., Ivnik R.J., Tangalos E.G., and Kokmen E. Mild cognitive impairment, clinical characterization and outcome. Arch. Neurol. 56 (1999) 303-308
51. Petersen R.C., Doody R., Kurz A., Mohs R.C., Morris J.C., Rabins P.V., Ritchie K., Rossor M., Thal L., and Winblad B. Current concepts in mild cognitive impairment. Arch. Neurol. 58 (2001) 1985-1992
52. Petersen R.C. Mild cognitive impairment as a diagnostic entity. J. Intern. Med. 256 (2004) 183-194
53. Petrides M. Specialized systems for the processing of mnemonic information within the primate frontal cortex. Philos. Trans. R. Soc. Lond. B. Biol. Sci. 351 (1996) 1455-1462
54. Salmond C.H., Ashburner J., Vargha-Khadem F., Connelly A., Gadian D.G., and Friston K.J. The precision of anatomical normalization in the medial temporal lobe using spatial basis functions. Neuroimage 17 (2002) 507-512
55. Scheltens P., Barkhof F., Leys D., Wolters E.C., Ravid R., and Kamphorst W. Histopathologic correlates of white matter changes on MRI in Alzheimer's disease and normal aging. Neurology 45 (1995) 883-888
56. Schmahmann J.D., and Pandya D.N. Fiber Pathways of the Brain (2006), Oxford University Press, New York 487-492 and p. 497-498
57. Senjem M.L., Gunter J.L., Shiung M.M., Petersen R.C., and Jack C.R. Comparison of different methodological implementations of voxel-based morphometry in neurodegenerative disease. NeuroImage 26 (2005) 600-608
58. Sled J.G., Zijdenbos A.P., and Evans A.C. A nonparametric method for automatic correction of intensity nonuniformity in MRI data. IEEE. Trans. Med. Imaging 17 (1998) 87-97
59. Smith C.D., Snowdon D.A., Wang H., and Markesbery W.R. White matter volumes and periventricular white matter hyperintensities in aging and dementia. Neurology 54 (2000) 838-842
60. Smith C.D., Chebrolu H., Andersen A.H., Powell D.A., Lovell M.A., Xiong S., and Gold B.T. White matter diffusion alterations in normal women at risk of Alzheimer's disease. Neurobiol. Aging (2008) (Sep 16, Electronic publication ahead of print)
61. Stahl R., Dietrich O., Teipel S.J., Hampel H., Reiser M.F., and Schoenberg S.O. White matter damage in Alzheimer disease and mild cognitive impairment: assessment with diffusion-tensor MR imaging and parallel imaging techniques. Radiology 243 (2007) 483-492
62. Sun S.W., Song S.K., Harms M.P., Lin S.J., Holtzman D.M., Merchant K.M., and Kotyk J.J. Detection of age-dependent brain injury in a mouse model of brain amyloidosis associated with Alzheimer's disease using magnetic resonance diffusion tensor imaging. Exp. Neurol. 191 (2005) 77-85
63. Sundgren P.C., Dong Q., Gómez-Hassan D., Mukherji S.K., Maly P., and Welsh R. Diffusion tensor imaging of the brain: review of clinical applications. Neuroradiology 46 (2004) 339-350
64. Sydykova D., Stahl R., Dietrich O., Ewers M., Reiser M.F., Schoenberg S.O., Möller H.J., Hampel H., and Teipel S.J. Fiber connections between the cerebral cortex and the corpus callosum in Alzheimer's disease: a diffusion tensor imaging and voxel-based morphometry study. Cereb. Cortex. 17 (2007) 2276-2282
65. Tang Y., Nyengaard J.R., Pakkenberg B., and Gundersen H.J. Age induced white matter changes in the human brain, a stereological investigation. Neurobiol. Aging 18 (1997) 609-615
66. Teipel S.J., Hampel H., Alexander G.E., Schapiro M.B., Horwitz B., Teichberg D., Daley E., Hippius H., Möller H.J., and Rapoport S.I. Dissociation between corpus callosum atrophy and white matter pathology in Alzheimer's disease. Neurology 51 (1998) 1381-1385
67. Teipel S.J., Hampel H., Pietrini P., Alexander G.E., Horwitz B., Daley E., Möller H.J., Schapiro M.B., and Rapoport S.I. Region-specific corpus callosum atrophy correlates with the regional pattern of cortical glucose metabolism in Alzheimer disease. Arch. Neurol. 56 (1999) 467-473
68. Teipel S.J., Bayer W., Alexander G.E., Zebuhr Y., Teichberg D., Kulic L., Schapiro M.B., Möller H.J., Rapoport S.I., and Hampel H. Progression of corpus callosum atrophy in Alzheimer disease. Arch. Neurol. 59 (2002) 243-248
69. Teipel S.J., Bayer W., Alexander G.E., Bokde A.L., Zebuhr Y., Teichberg D., Müller-Spahn F., Schapiro M.B., Möller H.J., Rapoport S.I., and Hampel H. Regional pattern of hippocampus and corpus callosum atrophy in Alzheimer's disease in relation to dementia severity, evidence for early neocortical degeneration. Neurobiol. Aging 24 (2003) 85-94
70. Tisserand D.J., Pruessner J.C., Sanz Arigita E.J., van Boxtel M.P., Evans A.C., Jolles J., and Uylings H.B. Regional frontal cortical volumes decrease differentially in aging: an MRI study to compare volumetric approaches and voxel-based morphometry. Neuroimage 17 (2002) 657-669
71. Thal D.R., Rub U., Orantes M., and Braak H. Phases of A beta-deposition in the human brain and its relevance for the development of AD. Neurology 58 (2002) 1791-1800
72. Thompson P.M., Moussai J., Zohoori S., Goldkorn A., Khan A.A., Mega M.S., Small G.W., Cummings J.L., and Toga A.W. Cortical variability and asymmetry in normal aging and Alzheimer's disease. Cereb. Cortex 8 (1998) 492-509
73. Thompson P.M., Hayashi K.M., de Zubicaray G., Janke A.L., Rose S.E., Semple J., Herman D., Hong M.S., Dittmer S.S., Doddrell D.M., and Toga A.W. Dynamics of gray matter loss in Alzheimer's disease. J. Neurosci. 23 (2003) 994-1005
74. Thomann P.A., Wustenberg T., Pantel J., Essig M., and Schroder J. Structural changes of the corpus callosum in mild cognitive impairment and Alzheimer's disease. Dement. Geriatr. Cogn. Disord. 21 (2006) 215-220
75. Tomaiuolo F., Scapin M., Di Paola M., Le Nezet P., Fadda L., Musicco M., Caltagirone C., and Collins D.L. Gross anatomy of the corpus callosum in Alzheimer's disease, regions of degeneration and their neuropsychological correlates. Dement. Geriatr. Cogn. Disord. 23 (2007) 96-103
76. Tomimoto H., Lin J.X., Matsuo A., Ihara M., Ohtani R., Shibata M., Miki Y., and Shibasaki H. Different mechanisms of corpus callosum atrophy in Alzheimer's disease and vascular dementia. J. Neurol. 251 (2004) 398-406
77. Ukmar M., Makuc E., Onor M.L., Garbin G., Trevisiol M., and Cova M.A. Evaluation of white matter damage in patients with Alzheimer's disease and in patients with mild cognitive impairment by using diffusion tensor imaging. Radiol. Med. 113 (2008) 915-922
78. Wang H., and Su M.Y. Regional pattern of increased water diffusivity in hippocampus and corpus callosum in mild cognitive impairment. Dement. Geriatr. Cogn. Disord. 22 (2006) 223-229
79. Wang P.J., Saykin A.J., Flashman L.A., Wishart H.A., Rabin L.A., Santulli R.B., McHugh T.L., MacDonald J.W., and Mamourian A.C. Regionally specific atrophy of the corpus callosum in AD, MCI and cognitive complaints. Neurobiol. Aging 27 (2006) 1613-1617
80. Weis S., Jellinger K., and Wenger E. Morphometry of the corpus callosum in normal aging and Alzheimer's disease. J. Neural. Transm. Suppl. 33 (1991) 35-38
81. Wiltshire K., Foster S., Kaye J.A., Small B.J., and Camicioli R. Corpus callosum in neurodegenerative diseases, findings in Parkinson's disease. Dement. Geriatr. Cogn. Disord. 20 (2005) 345-351
82. Witelson S.F. Hand and sex differences in the isthmus and genu of the human corpus callosum. A postmortem morphological study. Brain 112 (1989) 799-835
83. Yamauchi H., Fukuyama H., Nagahama Y., Katsumi Y., Hayashi T., Oyanagi C., Konishi J., and Shio H. Comparison of the pattern of atrophy of the corpus callosum in frontotemporal dementia, progressive supranuclear palsy, and Alzheimer's disease. J. Neurol. Neurosurg. Psychiatry 69 (2000) 623-629
84. Zarei M., Johansen-Berg H., Smith S., Ciccarelli O., Thompson A.J., and Matthews P.M. Functional anatomy of interhemispheric cortical connections in the human brain. J. Anat. 209 (2006) 311-320